Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective
Titel:
Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective
Auteur:
Grit, Geeske F van Geffen, Esmée Malmberg, Ruben van Leeuwen, Roelof Böhringer, Stefan JM Smit, Hans Brocken, Pepijn FH Eijsink, Job Dronkers, Esther Gal, Pim Jaarsma, Eva JHM van Drie-Pierik, Regine MP Eldering-Heldens, Anne Machteld Wymenga, AN GM Mol, Peter Zwaveling, Juliëtte Hilarius, Doranne